In April 2021, Rally Foundation For Childhood Cancer Research invested for the first time in Oncoheroes Biosciences. Today, we are thrilled to announce that Rally Foundation is investing again ba...
Read moreThe use of genetically modified T lymphocytes (CART lymphocytes) to recognize cancer cells increases the life expectancy of patients with chemotherapy-resistant lymphoma.
Read moreEn 2020 se diagnosticaron 313.959 casos de esta enfermedad en el mundo y 207.252 fallecieron. La elevada mortalidad se debe fundamentalmente al diagnóstico tardío. Un nuevo estudio permite predecir ...
Read moreUn año más, el Vall d’Hebron Instituto de Oncología (VHIO) y el Hospital Universitario Vall d’Hebron (HUVH) han programado un ciclo de jornadas online para 2022 en las que se abordarán diferen...
Read moreOncoheroes Biosciences, Inc. (“Oncoheroes”), and Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity”) have signed a worldwide, exclusive pediatric licensing agreement for dovitinib, a pan-t...
Read moreThe Src protein takes part in the regulation of many physiological processes such as the survival, migration or cell adhesion as a response to stimuli received from several receptors of the membrane. ...
Read moreInvestigadores del Departamento de Ciencias de la Salud de la Universidad de Jaén (UJA) han descrito el efecto antitumoral que tienen dos componentes minoritarios del Aceite de Oliva Virgen Extra (AO...
Read moreC2i Genomics, a cancer intelligence company, today announced expansion into Europe through a strategic partnership with OncoDNA, a genomic and theranostic company specializing in precision medicine fo...
Read moreThe international MOBI-Kids study analysed the relationship between use of mobile and cordless telephones and brain tumour risk in young people from 14 different countries. The study, coordinated by t...
Read moreA study published today in Cell Reports reveals important insights into the molecular mechanisms that underpin the body’s natural defences against the development of skin cancer. The findings offer ...
Read moreEl Dr. Alejandro Pérez-Fidalgo, investigador del Instituto de Investigación Sanitaria INCLIVA del Hospital Clínico de Valencia y miembro de GEICAM, ha colaborado en la puesta en marcha del ensayo c...
Read more